FDA panel wants to ban certain OTC asthma inhalers
An FDA advisory panel has voted 11-7 to recommend that the FDA ban certain nonprescription inhalers because they contain propellants that harm the ozone layer. Among the products that would be affected by a ban is Wyeth Consumer Healthcare's Primatene Mist.
Recent Videos
Related Content
Vitamin D3 Supplementation Does Not Lower Risk of T2D in Healthy Older Adults
December 4th 2024Article
A recent study found that, among older adults who are generally healthy and not at high risk for type 2 diabetes, Vitamin D3 supplementation does not significantly reduce the risk of developing the disease.
